Bibliography
- Papers of special note have been highlighted as either of interest (●) or of considerable interest (●●) to readers.
- Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy-A review. Epilepsy Res. 2009;85(1):31–45.
- Mula M, Cock HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015;22(1):24–30.
- Friedman D, Devinsky O. Canniboids in the treatment of epilepsy. New Engl J Med. 2015;373:1048–1058.
- Bialer M, Johannessen SI, Levy RH, et al. Progress report on new antiepileptic drugs: a summary of the Twelfth Eilat Conference (EILAT XII). Epilepsy Res. 2015;111:85–141.
●● Comprehensive overview of preclinical and clinical studies on investigational drugs for epilepsy.
- Gloss D, Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev. 2012;6(June):CD009270.
- Mazarati AM. Galanin and galanin receptors in epilepsy. Neuropeptides. 2004;38:331–343.
- Theodore WH, Hasler G, Giovacchini G, et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia. 2007;48(8):1526–1530.
- Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet. 2012;380(9848):1180–1192.
- Gentsch K, Heinemann U, Schmitz B, et al. Fenfluramine blocks low-Mg2+-induced epileptiform activity in rat entorhinal cortex. Epilepsia. 2000;41(8):925–928.
- Mula M. Emerging drugs for focal epilepsy. Expert Opin Emerg Drugs. 2013;18(1):87–95.
● Overview of drugs under development for focal epilepsy.
- Porta N, Vallée L, Lecointe C, et al. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia. 2009;50(4):943–948.
- Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology. 2014;83(21):1978–1985.
- Curatolo P, Moavero R. mTOR inhibitors as a new therapeutic option for epilepsy. Expert Rev Neurother. 2013;13:627–638.
- Abraham J, Fox PD, Condello C, et al. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis. 2012;46:425–430.
- Wykes RC, Kullmann DM, Pavlov I, et al. Optogenetic approaches to treat epilepsy. J Neurosci Methods. 2015. DOI:10.1016/j.jneumeth.2015.06.004. [Epub ahead of print].